Please Wait...

Key Cardiovascular Mergers and Acquisitions

With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in providing comprehensive services with unrivalled scientific and technical leadership.  Over the last decade, Bioclinica has grown organically and through strategic acquisitions to enhance and strengthen its cardiac safety expertise, resources and offerings for clinical trial sponsors.

In 2004, Bioclinica (formerly Bio-Imaging Technologies) acquired Heartcore BV, a global provider of centralized cardiovascular imaging analysis specializing in various quantitative image analysis services. In 2013, Bioclinica merged with Core Lab Partners, adding renowned scientific expertise from Medifacts to its cardiovascular team, bolstering its centralized cardiovascular services portfolio and expanding its presence in Asia.  Most recently, in 2014, Bioclinica merged with SYNARC, supplementing an already strong cardiac safety program with additional scientific expertise and operations in the area of Echocardiography and cardiovascular imaging.

Bioclinica continues to strengthen its cardiovascular offerings, providing sponsors with world-class expertise, operations and technology to design, manage, and analyze cardiac safety data in support of new treatments.

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (13 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (13 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (13 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (13 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (13 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (14 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices